Cleared Traditional

K181541 - Connect App for iHealth Next

K181541 is the FDA 510(k) clearance for Connect App for iHealth Next by Andon Health Co, Ltd.. It is a Class 2 Cardiovascular device (product code MWI) cleared through the Traditional 510(k) pathway after a 309-day FDA review.

K181541 · Andon Health Co, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
309d
Days
Class 2
Risk

K181541 is an FDA 510(k) clearance for the Connect App for iHealth Next, iHealth React Native SDK, iHealth React Native .... Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Andon Health Co, Ltd. (Tianjin, CN). The FDA issued a Cleared decision on April 16, 2019 after a review of 309 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Andon Health Co, Ltd. devices

Submission Details

510(k) Number K181541 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2018
Decision Date April 16, 2019
Days to Decision 309 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
184d slower than avg
Panel avg: 125d · This submission: 309d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K181541.
Masimo Rad-97 and Accessories
K183697 · Masimo Corporation · May 2019
Stasis Monitoring System
K183634 · Stasis Labs, Inc. · Apr 2019
SmartLinx Vitals Plus Patient Monitoring System
K183638 · Capsule Technologie · Apr 2019
Patient Monitor
K181919 · Guangdong Biolight Meditech Co., Ltd. · Apr 2019
3880 MRI Patient Monitoring System
K180903 · Iradimed Corporation · Mar 2019
Accutorr 7/VS-900/VS-900c Vital Signs Monitor
K182821 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Mar 2019